SCHEMBL5083145

SCHEMBL5083145

CCCCc1ccc(OC(CCNC)c2ccoc2)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 17/20 0.46
SLC6A2 P23975 17/20 0.46
SLC6A3 Q01959 4/20 0.41
CYP1A2 P05177 4/20 0.40
CYP3A4 P08684 4/20 0.40
CYP2D6 P10635 4/20 0.40
TSHR P16473 3/20 0.40
KMT2A Q03164 2/20 0.40
CHRM1 P11229 2/20 0.40
ADRA2B P18089 2/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HRH1 P35367 2/20 0.40
OPRM1 P35372 2/20 0.40
DRD3 P35462 2/20 0.40
OPRK1 P41145 2/20 0.40
HTR2B P41595 2/20 0.40
KCNH2 Q12809 2/20 0.40
KLF10 Q13118 2/20 0.40
HRH3 Q9Y5N1 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3282 0.94 SLC2A1 (0.43) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL16834368 0.79 SLC2A1 (0.41)
SCHEMBL23521674 0.73 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL30788068 0.73 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL21742882 0.73 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
Cadaverine Tartrate SCHEMBL3757 0.71 SLC6A4 (0.64) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL23521650 0.68 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL23521649 0.68 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL23761083 0.68 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL29975150 0.68 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133884-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-11-06 WO disclosed